| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advances in tuberculosis control during the past decade
|
Naidoo, Kogieleum
|
|
|
11 |
4 |
p. 311-313
|
article
|
| 2 |
Clinical case definition of post-COVID-19 condition in children: a good start, but improvements are needed
|
Burki, Talha
|
|
|
11 |
4 |
p. 314
|
article
|
| 3 |
Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment
|
Rangaka, Molebogeng X
|
|
|
11 |
4 |
p. 380-390
|
article
|
| 4 |
Concerns regarding a suggested long COVID paradigm
|
Schwendinger, Fabian
|
|
|
11 |
4 |
p. e33
|
article
|
| 5 |
Concerns regarding a suggested long COVID paradigm
|
van der Palen, Jenny
|
|
|
11 |
4 |
p. e34
|
article
|
| 6 |
Concerns regarding a suggested long COVID paradigm
|
Cornish, Flora
|
|
|
11 |
4 |
p. e35
|
article
|
| 7 |
Concerns regarding a suggested long COVID paradigm – Authors' reply
|
Saunders, Chloe
|
|
|
11 |
4 |
p. e36-e37
|
article
|
| 8 |
Continuation of enteral nutrition until extubation in critically ill patients
|
Lobmeyr, Elisabeth
|
|
|
11 |
4 |
p. 298-299
|
article
|
| 9 |
Continued enteral nutrition until extubation compared with fasting before extubation in patients in the intensive care unit: an open-label, cluster-randomised, parallel-group, non-inferiority trial
|
Landais, Mickaël
|
|
|
11 |
4 |
p. 319-328
|
article
|
| 10 |
Correction to Lancet Respir Med 2023; published online Feb 3. https://doi.org/10.1016/S2213-2600(22)00491-X
|
|
|
|
11 |
4 |
p. e38
|
article
|
| 11 |
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
|
Mayer-Hamblett, Nicole
|
|
|
11 |
4 |
p. 329-340
|
article
|
| 12 |
Do chest x-ray-positive, sputum-negative individuals warrant more attention during tuberculosis screening?
|
Kendall, Emily A
|
|
|
11 |
4 |
p. 304-306
|
article
|
| 13 |
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
|
Solomon, Benjamin J
|
|
|
11 |
4 |
p. 354-366
|
article
|
| 14 |
First-line lorlatinib for advanced ALK-positive non-small-cell lung cancer
|
Lin, Jessica J
|
|
|
11 |
4 |
p. 302-304
|
article
|
| 15 |
Kogie Naidoo—when one condition leads to another
|
Kirby, Tony
|
|
|
11 |
4 |
p. 315
|
article
|
| 16 |
Philip Morris ejected from Canadian vaccine collaboration
|
Kirby, Tony
|
|
|
11 |
4 |
p. e40
|
article
|
| 17 |
Respiratory syncytial virus-induced disease in healthy infants: we need to offload this burden
|
Bem, Reinout A
|
|
|
11 |
4 |
p. 301-302
|
article
|
| 18 |
Sedative medications: an avoidable cause of asthma and COPD exacerbations?
|
Chalitsios, Christos V
|
|
|
11 |
4 |
p. e31-e32
|
article
|
| 19 |
SIMPLIFYing cystic fibrosis treatment in a post-modulator era
|
Yang, Connie
|
|
|
11 |
4 |
p. 299-300
|
article
|
| 20 |
Stalking the Great Killer: Arkansas's Long War on Tuberculosis
|
Burki, Talha
|
|
|
11 |
4 |
p. 316
|
article
|
| 21 |
Surviving sepsis with multiple serious complications
|
Kirby, Tony
|
|
|
11 |
4 |
p. 317-318
|
article
|
| 22 |
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
|
Wildenbeest, Joanne G
|
|
|
11 |
4 |
p. 341-353
|
article
|
| 23 |
The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis
|
Sossen, Bianca
|
|
|
11 |
4 |
p. 367-379
|
article
|
| 24 |
Time to invest in tuberculosis research and disease control
|
The Lancet Respiratory Medicine,
|
|
|
11 |
4 |
p. 297
|
article
|
| 25 |
Tuberculosis and nutrition: what gets measured gets managed
|
McQuaid, C Finn
|
|
|
11 |
4 |
p. 308-310
|
article
|
| 26 |
US researchers call for FDA action to avoid another EVALI outbreak
|
Furlow, Bryant
|
|
|
11 |
4 |
p. e39
|
article
|
| 27 |
Vaccine anaphylaxis and Canadian public health policy
|
Abrams, Elissa M
|
|
|
11 |
4 |
p. 306-308
|
article
|
Journal description